Key points are not available for this paper at this time.
We have constructed a replication-defective adenovirus vector encoding the yeast I-SceI endonuclease under the control of the murine cytomegalovirus immediate-early gene promoter (AdMSceI) for efficient delivery of this enzyme to mammalian cells. We present evidence of AdMSceI-mediated I-SceI protein expression and cleavage activity in replicationpermissive 293 cells, and of cleavage of chromosomes in vivo in both 293 cells and in non-permissive human cells. We have exploited this system for the generation of chromosomes capped by artificial telomeric sequences in cells with integrated plasmids containing telomeric DNA arrays adjacent to an I-SceI recognition site. The properties of the AdMSceI virus described here make it a useful tool for studying biological processes involving induction of DNA breaks, recombination and gene targeting in cells grown in culture and in vivo.
Anglana et al. (Mon,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: